Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Janus Mesoporous Silica Nanoparticles for Dual Targeting of Tumor Cells and Mitochondria.

López V, Villegas MR, Rodríguez V, Villaverde G, Lozano D, Baeza A, Vallet-Regí M.

ACS Appl Mater Interfaces. 2017 Aug 16;9(32):26697-26706. doi: 10.1021/acsami.7b06906. Epub 2017 Aug 7.

PMID:
28759196
2.

Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues.

Villegas MR, Baeza A, Vallet-Regí M.

ACS Appl Mater Interfaces. 2015 Nov 4;7(43):24075-81. doi: 10.1021/acsami.5b07116. Epub 2015 Oct 21.

PMID:
26461206
3.

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study.

Raffi F, Rachlis A, Stellbrink HJ, Hardy WD, Torti C, Orkin C, Bloch M, Podzamczer D, Pokrovsky V, Pulido F, Almond S, Margolis D, Brennan C, Min S; SPRING-2 Study Group.

Lancet. 2013 Mar 2;381(9868):735-43. doi: 10.1016/S0140-6736(12)61853-4. Epub 2013 Jan 8.

PMID:
23306000
4.

Allelic frequency of six STR loci in five Colombian cities.

Durán R, Zarante I, Acevedo ML, Villegas MR, Salazar J, Bocanegra BY, Bernal J.

J Forensic Sci. 2003 Jul;48(4):887-8. No abstract available.

PMID:
12877314
5.

[Jorge Lobo's disease (keloid blastomycosis). Presentation of a new Colombian case].

Villegas MR.

Mycopathol Mycol Appl. 1965 Apr 14;25(3):373-80. Spanish. No abstract available.

PMID:
5877184

Supplemental Content

Loading ...
Support Center